Investor relations

ANGLE plc in the media

3 May 2024

Video interview on new commercial agreement with large pharma

24 April 2024
Video interview on AstraZeneca contract for DNA damage response assay

22 April 2024
Video interview on ANGLE’s patented CellKeep slide minimising cell loss for microscopy

4 January 2024
Video interview on breakthrough clinical results and large pharma contract

19 April 2023
Video interview on HER2 assay development partnership with BioView

22 June 2022
Video interview on new contract with large-scale pharma services customer

7 June 2022
Video interview with Master Investor

30 May 2022
Video interview on Prostate Cancer Agreement with major US Urology Group, Solaris Health

25 May 2022
Video interview on FDA Product Clearance for Parsortix system

16 April 2021
Video interview on First Large-Scale Pharma Services Contract

29 October 2020
Video interview on Parsortix FDA submission

28 September 2020
Video interview on FDA Submission

22 June 2020
Video interview on Blood Donations Recommenced

28 April 2020
Video interview on Business Update

11 March 2020
VOX Markets Podcast

22 January 2020
Interview on FDA Q-Submission Meeting

Request a meeting with